Prof. Jose M Mato, general director at CIC bioGUNE, discusses the use of NMR spectroscopy for metabolic profiling and screening of populations, and how the migration of advanced technology from translational research to the field of clinical diagnostics is enabling a personalized medicine approach for the future.